883 related articles for article (PubMed ID: 17624681)
1. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia.
Wakida K; Shimazawa M; Hozumi I; Satoh M; Nagase H; Inuzuka T; Hara H
Neuroscience; 2007 Aug; 148(1):105-14. PubMed ID: 17624681
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein-III knockout mice aggravates the neuronal damage after transient focal cerebral ischemia.
Koumura A; Hamanaka J; Shimazawa M; Honda A; Tsuruma K; Uchida Y; Hozumi I; Satoh M; Inuzuka T; Hara H
Brain Res; 2009 Oct; 1292():148-54. PubMed ID: 19635467
[TBL] [Abstract][Full Text] [Related]
3. Sustained astrocytic clusterin expression improves remodeling after brain ischemia.
Imhof A; Charnay Y; Vallet PG; Aronow B; Kovari E; French LE; Bouras C; Giannakopoulos P
Neurobiol Dis; 2006 May; 22(2):274-83. PubMed ID: 16473512
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation.
Zhang HL; Gu ZL; Savitz SI; Han F; Fukunaga K; Qin ZH
J Neurosci Res; 2008 Apr; 86(5):1132-41. PubMed ID: 18074385
[TBL] [Abstract][Full Text] [Related]
5. In vivo neuroprotection by a creatine-derived compound: phosphocreatine-Mg-complex acetate.
Perasso L; Adriano E; Ruggeri P; Burov SV; Gandolfo C; Balestrino M
Brain Res; 2009 Aug; 1285():158-63. PubMed ID: 19523930
[TBL] [Abstract][Full Text] [Related]
6. Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats.
Lukic-Panin V; Kamiya T; Zhang H; Hayashi T; Tsuchiya A; Sehara Y; Deguchi K; Yamashita T; Abe K
Brain Res; 2007 Oct; 1176():143-50. PubMed ID: 17904110
[TBL] [Abstract][Full Text] [Related]
7. Ischemia-related changes in naive and mutant forms of ubiquitin and neuroprotective effects of ubiquitin in the hippocampus following experimental transient ischemic damage.
Ahn HC; Yoo KY; Hwang IK; Cho JH; Lee CH; Choi JH; Li H; Cho BR; Kim YM; Won MH
Exp Neurol; 2009 Nov; 220(1):120-32. PubMed ID: 19666022
[TBL] [Abstract][Full Text] [Related]
8. Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
Penkowa M; Quintana A; Carrasco J; Giralt M; Molinero A; Hidalgo J
J Neurosci Res; 2004 Jul; 77(1):35-53. PubMed ID: 15197737
[TBL] [Abstract][Full Text] [Related]
9. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide protects against ischemic neuronal damage induced by focal cerebral ischemia in mice.
Hyakkoku K; Nakajima Y; Izuta H; Shimazawa M; Yamamoto T; Shibata N; Hara H
Neuroscience; 2009 Mar; 159(2):760-9. PubMed ID: 19166916
[TBL] [Abstract][Full Text] [Related]
11. Motheaten (me/me) mice deficient in SHP-1 are less susceptible to focal cerebral ischemia.
Beamer CA; Brooks DM; Lurie DI
J Neurosci Res; 2006 May; 83(7):1220-30. PubMed ID: 16528752
[TBL] [Abstract][Full Text] [Related]
12. Cilostazol reduces ischemic brain damage partly by inducing metallothionein-1 and -2.
Wakida K; Morimoto N; Shimazawa M; Hozumi I; Nagase H; Inuzuka T; Hara H
Brain Res; 2006 Oct; 1116(1):187-93. PubMed ID: 16952340
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice.
Keller M; Yang J; Griesmaier E; Gorna A; Sarkozy G; Urbanek M; Gressens P; Simbruner G
Neurobiol Dis; 2006 Nov; 24(2):357-66. PubMed ID: 16959492
[TBL] [Abstract][Full Text] [Related]
14. Enlarged infarct volume and loss of BDNF mRNA induction following brain ischemia in mice lacking FGF-2.
Kiprianova I; Schindowski K; von Bohlen und Halbach O; Krause S; Dono R; Schwaninger M; Unsicker K
Exp Neurol; 2004 Oct; 189(2):252-60. PubMed ID: 15380477
[TBL] [Abstract][Full Text] [Related]
15. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.
Zawadzka M; Kaminska B
Glia; 2005 Jan; 49(1):36-51. PubMed ID: 15390105
[TBL] [Abstract][Full Text] [Related]
16. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.
Yu YP; Xu QQ; Zhang Q; Zhang WP; Zhang LH; Wei EQ
Neurosci Lett; 2005 Oct; 387(1):5-10. PubMed ID: 16054296
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
Hurtado O; Moro MA; Cárdenas A; Sánchez V; Fernández-Tomé P; Leza JC; Lorenzo P; Secades JJ; Lozano R; Dávalos A; Castillo J; Lizasoain I
Neurobiol Dis; 2005 Mar; 18(2):336-45. PubMed ID: 15686962
[TBL] [Abstract][Full Text] [Related]
18. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia.
Yang C; Zhang X; Fan H; Liu Y
Brain Res; 2009 Jul; 1282():133-41. PubMed ID: 19445907
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein, an endogenous antioxidant, protects against retinal neuron damage in mice.
Suemori S; Shimazawa M; Kawase K; Satoh M; Nagase H; Yamamoto T; Hara H
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3975-82. PubMed ID: 16936113
[TBL] [Abstract][Full Text] [Related]
20. Spatial-temporal expression of NDRG2 in rat brain after focal cerebral ischemia and reperfusion.
Li Y; Shen L; Cai L; Wang Q; Hou W; Wang F; Zeng Y; Zhao G; Yao L; Xiong L
Brain Res; 2011 Mar; 1382():252-8. PubMed ID: 21241684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
